Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Concise Pharmaceutical Technology Development is a specialized pharmaceutical research and development organization based in Harbin, China. Established in 2010, the company focuses on the development of advanced drug delivery systems, particularly sustained-release and controlled-release formulations. They offer a range of services including pharmaceutical technology transfer, technical consultation, and the development of pharmaceutical intermediates. The company serves as a strategic partner for pharmaceutical manufacturers looking to enhance the pharmacokinetic profiles of existing compounds or develop complex generic products. Their expertise spans from early-stage formulation design to the industrialization of sophisticated dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Concise Pharmaceutical Technology Development.